| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P50 | author | Satinath Mukhopadhyay | Q43078714 |
| P2093 | author name string | Uttara Chatterjee | |
| Moitri Basu | |||
| Sib Sankar Roy | |||
| P2860 | cites work | Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation | Q24292720 |
| Structure and Expression of a Novel Member, FGF-16, of the Fibroblast Growth Factor Family | Q24311719 | ||
| FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development | Q24321511 | ||
| Fibroblast growth factors | Q24542507 | ||
| Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells | Q24645625 | ||
| Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells | Q24658237 | ||
| Fibroblast growth factors, their receptors and signaling | Q28140520 | ||
| Differential regulation of gene expression by PITX2 isoforms | Q28214392 | ||
| Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development | Q28216579 | ||
| The significance of PITX2 overexpression in human colorectal cancer | Q28235167 | ||
| PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter | Q45280595 | ||
| Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis | Q46552554 | ||
| Fgf16 is essential for pectoral fin bud formation in zebrafish | Q47073556 | ||
| Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinicopathologic study of 60 cases | Q53358319 | ||
| Structural and Functional Diversity in the FGf Receptor Multigene Family | Q55919452 | ||
| Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells | Q71637914 | ||
| Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer | Q74604702 | ||
| Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer | Q77827950 | ||
| Signal transduction by fibroblast growth factor receptors | Q78171822 | ||
| Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas | Q80406313 | ||
| Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5 | Q28242922 | ||
| Structural and functional diversity in the FGF receptor multigene family | Q28265126 | ||
| Expression of PITX2 homeodomain transcription factor during rat gonadal development in a sexually dimorphic manner | Q28305505 | ||
| Fibroblast growth factor signaling during early vertebrate development | Q28305654 | ||
| Promotion and attenuation of FGF signaling through the Ras-MAPK pathway | Q28312210 | ||
| FGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1(-/-) mice | Q28505123 | ||
| Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis | Q28507650 | ||
| Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development | Q28511544 | ||
| Differential expression of procollagen lysine 2-oxoglutarate 5-deoxygenase and matrix metalloproteinase isoforms in hypothyroid rat ovary and disintegration of extracellular matrix | Q28569277 | ||
| Fibroblast growth factor-16 is a growth factor for embryonic brown adipocytes | Q28571155 | ||
| Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo | Q28590848 | ||
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
| Fibroblast growth factor signalling: from development to cancer | Q29616827 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression | Q33719284 | ||
| TCF transcription factors: molecular switches in carcinogenesis | Q33755135 | ||
| Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. | Q33889677 | ||
| Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer | Q33914163 | ||
| Mechanisms underlying differential responses to FGF signaling | Q34415005 | ||
| Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer | Q34582207 | ||
| Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion | Q34695847 | ||
| Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment | Q35098085 | ||
| ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3. | Q35922535 | ||
| Wnt/β-Catenin Pathway Is Regulated by PITX2 Homeodomain Protein and Thus Contributes to the Proliferation of Human Ovarian Adenocarcinoma Cell, SKOV-3 | Q36596332 | ||
| Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta | Q36671104 | ||
| The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease | Q36961346 | ||
| Beyond chemotherapy: targeted therapies in ovarian cancer | Q37399899 | ||
| Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. | Q37453552 | ||
| FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development | Q37578056 | ||
| DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients | Q40060957 | ||
| Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas | Q40322109 | ||
| Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex | Q40626164 | ||
| Nuclear factor 1 and T-cell factor/LEF recognition elements regulate Pitx2 transcription in pituitary development | Q42412060 | ||
| Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins | Q44872922 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 1415-1428 | |
| P577 | publication date | 2013-11-19 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway | |
| P478 | volume | 289 |
| Q28395274 | A review of molecular events of cadmium-induced carcinogenesis |
| Q91283855 | Breakpoint mapping at nucleotide resolution in X-autosome balanced translocations associated with clinical phenotypes |
| Q98616931 | CD83, a Novel MAPK Signaling Pathway Interactor, Determines Ovarian Cancer Cell Fate |
| Q42509183 | Cellular Migration Ability Is Modulated by Extracellular Purines in Ovarian Carcinoma SKOV-3 Cells. |
| Q37094042 | Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients |
| Q38706721 | Co-Activation of TGFβ and Wnt Signalling Pathways Abrogates EMT in Ovarian Cancer Cells |
| Q92369608 | Downregulation of LINC00515 in high-grade serous ovarian cancer and its relationship with platinum resistance |
| Q38706521 | Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes |
| Q41935600 | Expression and purification of an FGF9 fusion protein in E. coli, and the effects of the FGF9 subfamily on human hepatocellular carcinoma cell proliferation and migration. |
| Q88334238 | Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer |
| Q35748595 | FGF signaling supports Drosophila fertility by regulating development of ovarian muscle tissues |
| Q98906651 | FGF/FGFR signaling in health and disease |
| Q89110921 | FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming |
| Q38887615 | FGFs: crucial factors that regulate tumour initiation and progression. |
| Q38753397 | Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells |
| Q38238222 | Heart-specific expression of FGF-16 and a potential role in postnatal cardioprotection |
| Q35965933 | Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer |
| Q50443999 | High-yield of biologically active recombinant human fibroblast growth factor-16 in E. coli and its mechanism of proliferation in NCL-H460 cells |
| Q55195623 | Increased Expression of Holliday Junction-Recognizing Protein (HJURP) as an Independent Prognostic Biomarker in Advanced-Stage Serous Ovarian Carcinoma. |
| Q35988303 | Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A. |
| Q90836027 | LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15 |
| Q38715858 | Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1. |
| Q38248852 | Metabolomics in cell culture--a strategy to study crucial metabolic pathways in cancer development and the response to treatment |
| Q50129419 | MiR-520f promotes cell aggressiveness by regulating fibroblast growth factor 16 in hepatocellular carcinoma |
| Q91775031 | MiRNA-144-3p inhibits high glucose induced cell proliferation through suppressing FGF16 |
| Q93365856 | MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway |
| Q97092580 | Molecular characterization of fibroblast growth factor-16 and its role in promoting the differentiation of intramuscular preadipocytes in goat |
| Q100401931 | Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro |
| Q39069743 | Reduction of doxorubicin-induced cardiotoxicity using nanocarriers: A review |
| Q36020564 | Regulatory Differences in Natal Down Development between Altricial Zebra Finch and Precocial Chicken. |
| Q38244309 | Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives |
| Q49415788 | Salvianolic acid B suppresses cell proliferation and induces apoptosis in osteosarcoma through p38-mediated reactive oxygen species generation |
| Q36998200 | Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer |
| Q34467171 | The Fibroblast Growth Factor signaling pathway |
| Q38540713 | The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. |
| Q36716292 | Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis |
Search more.